HIV-associated neurocognitive disorders and the impact of combination antiretroviral therapies

Current Neurology and Neuroscience Reports

Volumn 8, Issue 6, 2008, Pages 455-461

  Ances, Beau M ^a   Clifford, David B ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BEHAVIOR; DIFFERENTIAL DIAGNOSIS; DRUG COMBINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY;

AIDS DEMENTIA COMPLEX; ANTI-HIV AGENTS; BEHAVIOR; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE IMAGING; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS;

EID: 58149198080     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-008-0073-3     Document Type: Article

References (50)

1. Gartner S, Markovits P, Markovitz DM, et al.: Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS. JAMA 1986, 256:2365-2371. (Pubitemid 17174464)
2. Navia BA, Cho ES, Petito CK, Price RW: The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986, 19:525-535. (Pubitemid 16085186)
3. Navia BA, Jordan BD, Price RW: The AIDS dementia complex: I. Clinical features. Ann Neurol 1986, 19:517-524. (Pubitemid 16085185)
4. Price RW, Navia BA, Cho ES: AIDS encephalopathy. Neurol Clin 1986, 4:285-301. (Pubitemid 16022690)
5. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 1991, 41:778-785.
6. Sacktor NC, Bacellar H, Hoover DR, et al.: Psychomotor slowing in HIV infection: a predictor of dementia, AIDS and death. J Neurovirol 1996, 2:404-410. (Pubitemid 27011093)
7. Wilkie FL, Goodkin K, Eisdorfer C, et al.: Mild cognitive impairment and risk of mortality in HIV-1 infection. J Neuropsychiatry Clin Neurosci 1998, 10:125-132. (Pubitemid 28241360)
8. Valcour VG, Shikuma CM, Watters MR, Sacktor NC: Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. AIDS 2004, 18 (Suppl 1):S79-S86. (Pubitemid 38365910)
9. Sacktor N, Lyles RH, Skolasky R, et al.: HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology 2001, 56:257-260. (Pubitemid 32095372)
10. Ferrando S, Van Gorp W, McElhiney M, et al.: Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 1998, 12:F65-F70. (Pubitemid 28241393)
11. Starace F, Bartoli L, Aloisi MS, et al.: Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study. Cognitive impairment and depression in HIV/AIDS. The NeuroICONA study. Acta Psychiatr Scand 2002, 106:20-26. (Pubitemid 34828144)
12. Ellis R, Langford D, Masliah E: HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 2007, 8:33-44. (Pubitemid 46011997)
13. Antinori A, Arendt G, Becker JT, et al.: Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007, 69:1789-1799. (Pubitemid 350059308)
14. Gonzalez RG, Cheng LL, Westmoreland SV, et al.: Early brain injury in the SIV-macaque model of AIDS. AIDS 2000, 14:2841-2849. (Pubitemid 32042747)
15. Gray F, Lescs MC, Keohane C, et al.: Early brain changes in HIV infection: neuropathological study of 11 HIV seropositive, non-AIDS cases. J Neuropathol Exp Neurol 1992, 51:177-185.
16. Kaul M, Garden GA, Lipton SA: Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001, 410:988-994. (Pubitemid 32335850)
17. Ricardo-Dukelow M, Kadiu I, Rozek W, et al.: HIV-1 infected monocyte-derived macrophages affect the human brain microvascular endothelial cell proteome: new insights into blood-brain barrier dysfunction for HIV-1-associated dementia. J Neuroimmunol 2007, 185:37-46. (Pubitemid 46497432)
18. Gonzalez-Scarano F, Martin-Garcia J: The neuropathogenesis of AIDS. Nat Rev Immunol 2005, 5:69-81. (Pubitemid 40070332)
19. Price RW: The two faces of HIV infection of cerebrospinal fluid. Trends Microbiol 2000, 8:387-391.
20. Strain MC, Letendre S, Pillai SK, et al.: Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005, 79:1772-1788. (Pubitemid 40459123)
21. Achim CL, Wiley CA: Inflammation in AIDS and the role of the macrophage in brain pathology. Curr Opin Neurol 1996, 9:221-225. (Pubitemid 26242675)
22. Adamson DC, Wildemann B, Sasaki M, et al.: Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996, 274:1917-1921. (Pubitemid 26424773)
23. Nottet HS, Gendelman HE: Unraveling the neuroimmune mechanisms for the HIV-1-associated cognitive/motor complex. Immunol Today 1995, 16:441-448.
24. Sharer LR: Pathology of HIV-1 infection of the central nervous system. A review. J Neuropathol Exp Neurol 1992, 51:3-11.
25. Masliah E, Heaton RK, Marcotte TD, et al.: Dendritic injury is a pathological substrate for human immunodefi-ciency virus-related cognitive disorders. HNRC Group. The HIV Neurobehavioral Research Center. Ann Neurol 1997, 42:963-972. (Pubitemid 28008427)
26. Langford D, Marquie-Beck J, De Almeida S, et al.: Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients. J Neurovirol 2006, 12:100-107. (Pubitemid 44574601)
27. Ances BM, Ellis RJ: Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007, 27:86-92. (Pubitemid 46239043)
28. Castellon SA, Hinkin CH, Wood S, Yarema KT: Apathy, depression, and cognitive performance in HIV-1 infection. J Neuropsychiatry Clin Neurosci 1998, 10:320-329. (Pubitemid 28369628)
29. Power C, Selnes OA, Grim JA, McArthur JC: HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:273-278.
30. Smith CA, Van Gorp WG, Ryan ER, et al.: Screening subtle HIV-related cognitive dysfunction: the clinical utility of the HIV dementia scale. J Acquir Immune Defic Syndr 2003, 33:116-118. (Pubitemid 36547251)
31. Wojna V, Nath A: Challenges to the diagnosis and management of HIV dementia. AIDS Read 2006, 16:615-616, 621-614, 626, 629-632.
32. Clifford DB, Yang Y, Evans S: Neurologic consequences of hepatitis C and human immunodeficiency virus coinfection. J Neurovirol 2005, 11 (Suppl 3):67-71.
33. Clifford DB, Evans S, Yang Y, et al.: Impact of efavirenz on neuropsychological performance and symptoms in HIVinfected individuals. Ann Intern Med 2005, 143:714-721.
34. Hestad K, McArthur JH, Dal Pan GJ, et al.: Regional brain atrophy in HIV-1 infection: association with specific neuropsychological test performance. Acta Neurol Scand 1993, 88:112-118. (Pubitemid 23247973)
35. Ernst T, Chang L, Arnold S: Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage 2003, 19:1686-1693. (Pubitemid 37025864)
36. Meyerhoff DJ, Bloomer C, Cardenas V, et al.: Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Neurology 1999, 52:995-1003. (Pubitemid 29161610)
37. Ragin AB, Storey P, Cohen BA, et al.: Whole brain diffusion tensor imaging in HIV-associated cognitive impairment. AJNR Am J Neuroradiol 2004, 25:195-200. (Pubitemid 38235295)
38. Chang L, Tomasi D, Yakupov R, et al.: Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol 2004, 56:259-272. (Pubitemid 39037921)
39. Ances BM, Roc AC, Wang J, et al.: Caudate blood flow and volume are reduced in HIV+ neurocognitively impaired patients. Neurology 2006, 66:862-866. (Pubitemid 43739761)
40. Cysique LA, Brew BJ, Halman M, et al.: Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. J Acquir Immune Defic Syndr 2005, 39:426-429. (Pubitemid 41003788)
41. Ellis RJ, Hsia K, Spector SA, et al.: Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group. Ann Neurol 1997, 42:679-688. (Pubitemid 27481539)
42. Price RW, Epstein LG, Becker JT, et al.: Biomarkers of HIV-1 CNS infection and injury. Neurology 2007, 69:1781-1788. (Pubitemid 350059307)
43. Gisslen M, Hagberg L, Brew BJ, et al.: Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex. J Infect Dis 2007, 195:1774-1778. (Pubitemid 46870250)
44. Brew BJ, Pemberton L, Blennow K, et al.: CSF amyloid beta42 and tau levels correlate with AIDS dementia complex. Neurology 2005, 65:1490-1492. (Pubitemid 41552790)
45. Hinkin CH, Castellon SA, Durvasula RS, et al.: Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002, 59:1944-1950. (Pubitemid 36076569)
46. Venkataramana A, Pardo CA, McArthur JC, et al.: Immune reconstitution inflammatory syndrome in the CNS of HIVinfected patients. Neurology 2006, 67:383-388. (Pubitemid 44214957)
47. Letendre S, Marquie-Beck J, Capparelli E, et al.: Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008, 65:65-70.
48. Ances BM, Roc AC, Korczykowski M, et al.: Combination anti-retroviral therapy modulates the blood oxygen level dependent amplitude in HIV+ patients. J Neurovirol 2008 (in press).
49. Sacktor N, Schifitto G, McDermott MP, et al.: Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study. Neurology 2000, 54:233-235. (Pubitemid 30038769)
50. Zink MC, Uhrlaub J, De Witt J, et al.: Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005, 293:2003-2011 (Pubitemid 40570894)